Inhaled Insulin Has Little Effect on Lung Function

COPENHAGEN — Two-year data on the only approved inhaled-insulin treatment show that it has minimal adverse effects on pulmonary function, according to two new studies supported by Pfizer Inc., which manufactures the product (Exubera).